These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [A case of gastric malignant lymphoma markedly responding to chronic daily and oral administration of low-dose etoposide].
    Author: Moriya A, Ikeda A, Yokoyama N, Yokoyama T, Abe Y, Miyamoto K.
    Journal: Gan To Kagaku Ryoho; 1993 Nov; 20(14):2229-33. PubMed ID: 8239691.
    Abstract:
    A 71-year-old woman was diagnosed as malignant lymphoma (non-Hodgkin's lymphoma, diffused mixed cell type) which involved gastric lesions. Combined chemotherapies were undertaken using VCR, CPA, 4-epi-ADM and PRED and then etoposide, 4-epi-ADM and PRED. After about 5 months, recurrent lesions were revealed in the right supraclavicular lymph node, so we conducted additional chemotherapy. However, the patient rejected intravenous therapy and required out-patient therapy, so daily oral administration of etoposide (50 mg/day) was carried out. Because of the toxicities of alopecia, the dose was reduced to 50 mg every other day, then to 25 mg every other day. No recurrent signs have been seen for the past 3 years. Bone marrow suppression was little. Chronic oral administration of low-dose etoposide is the potential salvage therapy of gastric malignant lymphoma.
    [Abstract] [Full Text] [Related] [New Search]